Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000814133-22-000068
Filing Date
2022-02-11
Accepted
2022-02-11 13:24:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 lgnd222.txt SC 13G/A 2471
  Complete submission text file 0000814133-22-000068.txt   4003
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS INC (Filed by) CIK: 0000814133 (see all company filings)

EIN.: 870319391 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 22618973
SIC: 2834 Pharmaceutical Preparations